Hyperfine, Inc. HYPR
0.52 USD -0.02 (-4.40%)
As ofNov 19, 2026, 3:51 PM EST
0.5204 Day range 0.5597
0.5204 52-week range 1.94
- YTD
- -46.79%
- 1 year
- -51.32%
Benzinga news
benzinga.com B. Riley Securities Reiterates Buy on Hyperfine, Lowers Price Target to $1.4 B. Riley Securities analyst Yuan Zhi reiterates Hyperfine (NASDAQ:HYPR) with a Buy and lowers the price target from $1.6 to $1.4.
benzinga.com Hyperfine Q3 2026 Earnings Call Transcript Hyperfine (NASDAQ:HYPR) reported third-quarter financial results on Monday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…benzinga.com Hyperfine Affirms FY2026 Sales Guidance of $20.000M-$22.000M vs $20.425M Est Hyperfine (NASDAQ:HYPR) affirms FY2026 sales outlook from $20.000 million-$22.000 million to $20.000 million-$22.000 million vs $20.425 million estimate.
benzinga.com Hyperfine Q3 EPS $(0.06) Beats $(0.08) Estimate, Sales $5.960M Beat $5.840M Estimate Hyperfine (NASDAQ:HYPR) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.08) by 25 percent. This is a 57.14 percent increase over losses of $(0.14) per…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Axogen (NASDAQ:AXGN) stock rose 17.7% to $44.1 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.1 billion. As per the news, the Q3 earnings report…benzinga.com Lucid Capital Markets Initiates Coverage On Hyperfine with Buy Rating, Announces Price Target of $2 Lucid Capital Markets analyst Alex Nowark initiates coverage on Hyperfine (NASDAQ:HYPR) with a Buy rating and announces Price Target of $2.
